Denosumab-induced hypocalcemia post bariatric surgery—a severe and protracted course: a case report [PDF]
, 2023 Mohd Hazriq Awang +3 more
openalex +1 more source
O papel do osteoclasto na fisiopatologia de doenças do aparelho locomotor e na condição de alvo terapêutico [PDF]
, 2013 O osteoclasto é uma célula especializada, cuja principal função é a reabsorção óssea. Está envolvida na patogénese da osteoporose, da Doença de Paget e das metástases ósseas, entre outras.
Judas, F, Silva, P
core
Extended Efficacy and Safety of Denosumab in Breast Cancer Patients with Bone Metastases Not Receiving Prior Bisphosphonate Therapy [PDF]
, 2008 Allan Lipton +15 more
openalex +1 more source
Correspondence to “Denosumab-induced hypocalcemia in patients with osteoporosis: can you know who will get low?” [PDF]
, 2020 Peiyan Ho +3 more
openalex +1 more source
Il trattamento riabilitativo integrato alla terapia farmacologica con anticorpo anti RANK-L [PDF]
, 2015 pubblicato su atti ...
Asaro, C. +6 more
core
Une complication rare de la grossesse dans la région du sacrum [PDF]
, 2018 A
Anisau, Aliaksandr, Vanhoenacker, Filip
core +1 more source
Denosumab combined with en bloc resection and arthrodesis for recurrent grade 3 giant cell tumor of bone in distal radius [PDF]
Zhuoyu Li
openalex +1 more source
Delayed Denosumab Injections and Bone Mineral Density Response: An Electronic Health Record-based Study [PDF]
, 2020 Houchen Lyu +7 more
openalex +1 more source
Inflammatory osteolysis: A conspiracy against bone [PDF]
, 2017 Abu-Amer +36 more
core +2 more sources
Denosumab: an investigational drug for the management of postmenopausal osteoporosis
Biologics: Targets & Therapy, 2008 E Michael LewieckiNew Mexico Clinical Research & Osteoporosis Center, Albuquerque, New Mexico, USAAbstract: Denosumab (AMG 162) is an investigational fully human monoclonal antibody with a high affinity and specificity for receptor activator of ...
E Michael Lewiecki
doaj